About the Company
DSV A/S is a Danish transport and logistics company offering global transport services by road, air, sea and train. Since its foundation in 1976 by nine independent Danish hauliers, the company has achieved rapid expansion and international presence, predominantly through a series of strategic competitor acquisitions, some of the most important ones being Samson Transport (1997), DFDS Dan Transport Group (2000), J.H.Bachmann (2004), Frans Maas (2006), ABX LOGISTICS (2008), UTi Worldwide, Inc. (2016), Panalpina Welttransport (Holding) AG (2019) and Agility Global Integrated Logistics (GIL) (2021). With headquarters in Hedehusene (near Copenhagen), Denmark, and offices in more than 80 countries, DSV employs more than 75,000 people and collaborates with partners and agents globally. The company is listed on NASDAQ OMX Copenhagen (Copenhagen Stock Exchange) and included in the OMXC25 index as one of the 25 most traded stocks. The company is structured in three divisions, Road, Air & Sea, and Solutions. Its main activities lie within road transport (trucking) networks in Europe, North America and South Africa, global air and sea freight forwarding business, and contract logistics across the globe. As part of an asset-light financial strategy to maintain fixed costs at a minimum and be able to quickly respond to market fluctuations, the group does not own any ships or aeroplanes and only a relatively small fleet of trucks and trailers. Jens Lund became CEO in February 2024. In 2022, the company reported a net revenue of DKK 235,665 million.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CHFS News
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate ...
Ultrafiltration in Acute Decompensated Heart Failure
CHF Solutions, Brooklyn Park, MN]. In RAPID-CHF, [7] 40 patients with heart failure were randomized to Aquadex ultrafiltration for 8 hours followed by diuretics as needed or standard medical ...
scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 ...
Intravenous Therapy for Hypertensive Emergencies, Part 2
Dr. Peacock has served on the scientific advisory boards or speakers' bureaus of or received research grants from Abbott, BAS, Beckman-Coulter, Biosite, Brahms, CHF Solutions, Heartscape ...
Global Restrictive Cardiomyopathy Treatment Market for Spectacular Growth, Projected to Reach US$ 179.08 Million at a CAGR of 6% by 2033
The Global Restrictive Cardiomyopathy Treatment Market is predicted to reach US$100 million in 2023 and US$179.08 million by ...
Cardiovascular Digital Solutions Market Key Segments, Share, Trends, Size, Growth, and Forecast 2024 to 2032
Report Ocean recently added a research report on “Cardiovascular Digital Solutions Market”. The report includes an extensive ...
Arbonia divests the Climate Division for EUR 760 million to Midea
Arbonia AG / Key word (s): Disposal Arbonia divests the Climate Division for EUR 760 million to Midea 18-Apr-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer ...
Scientists worldwide in line for US$1.1 million Frontiers Planet Prize as 2024 National Champions announced
Johan Rockström. Frontiers Planet Prize recognizes scientists whose research contributes to accelerating solutions that ensure humanity remains safely within the boundaries of the Earth's ecosystem.
Amundi Msci Che Regulatory News
8th Apr 2024 8:20 am EQS Amundi MSCI Switzerland UCITS ETF - CHF (C): Net Asset Value(s) 5th Apr 2024 8:15 am EQS Amundi MSCI Switzerland UCITS ETF - CHF (C): Net Asset Value(s) 5th Apr 2024 8:15 ...
UBS (Irl) Fund Solutions plc – MSCI ACWI SF UCITS ETF
UBS Asset Management (Singapore) Ltd.
Loading the latest forecasts...